Seeking Alpha

MannKind (MNKD) and Tolero Pharmaceuticals announce a license agreement granting Tolero...

MannKind (MNKD) and Tolero Pharmaceuticals announce a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MNKD's Bruton's tyrosine kinase program for the treatment of hematological malignancies and inflammatory diseases. MNKD +7.1% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)